Imperial College London

Professor Amanda Cross

Faculty of MedicineSchool of Public Health

Professor of Cancer Epidemiology



+44 (0)20 7594 3338amanda.cross




Mr Will Kay +44 (0)20 7594 3350




Norfolk PlaceSt Mary's Campus





Professor Cross is a cancer epidemiologist in the Department of Epidemiology and Biostatistics within the School of Public Health, Faculty of Medicine of Imperial College. She is also the Head of the Cancer Screening and Prevention Research Group ( the Department of Surgery and Cancer at Imperial.

She completed her PhD at Cambridge University and then obtained a post-doctoral fellowship within the Division of Cancer Epidemiology and Genetics (DCEG) at the National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, United States. After two years of post-doctoral research, Dr. Cross was awarded a research fellowship and shortly after became a tenure-track investigator at NCI. During her time as an investigator at NCI, she was also a mentor for the Yale University– NCI Partnership Training Program and held the position of Assistant Professor Adjunct within the Division of Chronic Disease Epidemiology at Yale University, New Haven, Connecticut.  Dr. Cross received the NIH Fellows Award for Research Excellence, the DCEG Fellowship Achievement Award for Outstanding Accomplishments, the DCEG Award for Outstanding Research Paper by a Fellow, the NCI Mentor of Merit Award, and the NIH Merit Award for Leadership of an Innovative Multidisciplinary Research Program.

Between 2005 and 2013, Dr. Cross was Principal Investigator of two colonoscopy screening studies (the Polyp Prevention Trial and the CONCeRN study), a metabolomics initiative within DCEG, and she was also one of the Principal Investigators of the U.S. Polyp Pooling Project. In 2013, Dr. Cross joined Imperial College to pursue her research interests in gastrointestinal malignancies and etiologic studies of lifestyle factors and cancer risk.



Mayen A-L, Viallon V, Botteri E, et al., 2022, A longitudinal evaluation of alcohol intake throughout adulthood and colorectal cancer risk, European Journal of Epidemiology, ISSN:0393-2990

Clasen JL, Heath AK, Van Puyvelde H, et al., 2022, Biomarkers of the transsulfuration pathway and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC) study, International Journal of Cancer, Vol:151, ISSN:0020-7136, Pages:708-716

Woodfield G, Belluomo I, Laponogov I, et al., 2022, Diagnostic performance of a non-invasive breath test for colorectal cancer: COBRA1 study, Gastroenterology, ISSN:0016-5085

Chan SSM, Chen Y, Casey K, et al., 2022, Obesity is associated with increased risk of Crohn's disease, but not ulcerative colitis: a pooled analysis of five prospective cohort studies, Clinical Gastroenterology and Hepatology, Vol:20, ISSN:1542-3565, Pages:1048-1058

Rothwell JA, Murphy N, Bešević J, et al., 2022, Metabolic signatures of healthy lifestyle patterns and colorectal cancer risk in a European cohort, Clinical Gastroenterology and Hepatology, Vol:20, ISSN:1542-3565, Pages:e1061-e1082

More Publications